What's the buzz

What's the buzz

Using mobile for 15 min. ups cancer risk
A new research has indicated that using a mobile phone for just 15 minutes a day can substantially increase the risk of brain cancer among its users.

A series of studies across 13 countries found that the longer people used their mobile, the higher was the risk. Elisabeth Cardis, leader of the Interphone Study, said an increased risk of brain tumours, known as gliomas, was seen in the 20 per cent of users with the highest exposure to radio-frequency emissions.

She said there was an increased risk of brain cancer close to where users held the phones to their heads.

Those who had used handsets for 15 minutes a day for seven years, showed a 72 per cent higher incidence of gliomas. Gliomas are fatal, usually within three to five years of diagnosis, even with treatment.

Cinnamon can help  prevent Alzheimer’s
Cinnamon when consumed in appropriate quantity can help prevent Alzheimer’s disease, according to a recent study.

A team of researchers, headed by Prof Michael Ovadia, have succeeded in extracting a substance from cinnamon that is capable of inhibiting the formation of toxic ß-amyloid polypeptide oligomers, which disassembles ß-amyloid fibrils, whose accumulation in the brain cells kills the neurons in Alzheimer’s patients, a university press release said.
The researchers have warned people not to rush to consume large quantities of raw cinnamon (more than 10 gms per day) as it also contains substances that are toxic to the liver.

 Ovadia had found that an extract from the bark of the cinnamon plant possesses the ability to inhibit the infectivity of ‘enveloped’ viruses, such as influenza,  HIV etc.

New drug to stop one in five heart attack deaths 
A new drug has boosted hopes of preventing at least one out of five deaths caused due to a heart attack, currently being treated with the traditional drug clopidogrel.

Robert Storey, Professor of Cardiology, University of Sheffield’s, has found that ticagrelor is more effective in reducing deaths and recurrent heart attacks than clopidogrel.  
A study on over 18,000 patients in over 40 countriesshowed that ticagrelor is just as effective at reducing deaths in patients over the age of 75 as in younger patients.
A sub-study has also confirmed that patients treated with clopidogrel, who have a genetic variant, have a slightly higher risk in the first month following a heart attack.


DH Newsletter Privacy Policy Get top news in your inbox daily
Comments (+)